Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from Stemedica Cell Technologies Inc. for the manufacturing, exploration and commercialization of therapeutic cardiovascular indications.